Information Provided By:
Fly News Breaks for July 15, 2019
BX, TRI
Jul 15, 2019 | 07:42 EDT
BofA Merrill Lynch analyst Gary Bisbee reinstated coverage of Thomson Reuters (TRI) with a Neutral rating and $70 price target, telling investors that the company's sale of a 55% stake in Refinitiv to Blackstone (BX) is a win-win and that the "new" Thomson is a "cleaner, faster growth story." However, he also sees this being largely priced in after a run-up in the stock over the last twelve months.
News For TRI;BX From the Last 2 Days
BX
Mar 27, 2024 | 06:37 EDT
Blackstone (BX) announced a new collaboration with Moderna (MRNA) through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750M to fund Moderna's influenza program. This new collaboration continues Blackstone Life Sciences' work and support for many of the world's leading and most innovative biopharmaceutical and medical technology companies. Blackstone seeks to provide customized financing solutions for companies across therapeutic areas to support mission critical scientific innovation and advance important products to patients.